MagicMed Industries Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
MagicMed Industries intends to partner with pharmaceutical and other companies to develop and commercialize psychedelic-derived pharmaceutical candidates. MagicMed's psychedelic derivatives library, the PsybraryTM, is intended to be an essential building block from which the industry can develop new patented products. The initial focus of the PsybraryTM is on psilocybin and DMT derivatives, and the PsybraryTM is then expected to be expanded to other psychedelics such as MDMA, LSD, mescaline, and ibogaine.
Company Type:
Privately Funded Company
Company HQ State:
Alberta
Company HQ Country:
Canada
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
Psilocybin, DMT, MDMA, LSD, Mescaline, and Ibogaine
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
MagicMed Industries Inc.